Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, <i>in silico</i> molecular docking and dynamics simulation-Reference-Cited by-同舟云学术

Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation

Author:

El-Hddad Sanadelaslam S. A.¹^ORCID,Sobhy Mohamed H.²,El-morsy Ahmed³,Shoman Nabil A.⁴^ORCID,El-Adl Khaled²⁵^ORCID

Affiliation:

1. Pharmaceutical Chemistry Department, Faculty of Pharmacy, Omar Almukhtar University, Al Bayda 991, Libya

2. Chemistry Department, Faculty of Pharmacy, Heliopolis University for Sustainable Development, Cairo, Egypt

3. Pharmaceutical Chemistry Department, College of Pharmacy, The Islamic University, Najaf, Iraq

4. Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt

5. Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo11884, Egypt

Abstract

This paper presents an extensive analysis of COVID-19 with a specific focus on VEGFR-2 inhibitors as potential treatments.

Publisher

Royal Society of Chemistry (RSC)

Link

Reference62 articles.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献